Vertex Pharmaceuticals Inc (VRTX)
418.99
+0.17
(+0.04%)
USD |
NASDAQ |
May 09, 16:00
419.22
+0.23
(+0.05%)
After-Hours: 20:00
Vertex Pharmaceuticals Gross Profit Margin (Quarterly): 87.27% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 87.27% |
| December 31, 2023 | 85.38% |
| September 30, 2023 | 87.17% |
| June 30, 2023 | 87.62% |
| March 31, 2023 | 88.76% |
| December 31, 2022 | 87.70% |
| September 30, 2022 | 87.60% |
| June 30, 2022 | 88.08% |
| March 31, 2022 | 88.28% |
| December 31, 2021 | 88.06% |
| September 30, 2021 | 88.08% |
| June 30, 2021 | 87.29% |
| March 31, 2021 | 88.85% |
| December 31, 2020 | 87.52% |
| September 30, 2020 | 87.90% |
| June 30, 2020 | 87.90% |
| March 31, 2020 | 89.27% |
| December 31, 2019 | 86.91% |
| September 30, 2019 | 86.11% |
| June 30, 2019 | 85.58% |
| March 31, 2019 | 88.92% |
| December 31, 2018 | 85.95% |
| September 30, 2018 | 85.82% |
| June 30, 2018 | 86.12% |
| March 31, 2018 | 88.82% |
| Date | Value |
|---|---|
| December 31, 2017 | 87.10% |
| September 30, 2017 | 87.40% |
| June 30, 2017 | 86.91% |
| March 31, 2017 | 93.43% |
| December 31, 2016 | 86.81% |
| September 30, 2016 | 86.93% |
| June 30, 2016 | 89.52% |
| March 31, 2016 | 87.28% |
| December 31, 2015 | 84.83% |
| September 30, 2015 | 89.68% |
| June 30, 2015 | 89.85% |
| March 31, 2015 | 91.11% |
| December 31, 2014 | 90.30% |
| September 30, 2014 | 92.08% |
| June 30, 2014 | 87.50% |
| March 31, 2014 | 86.93% |
| December 31, 2013 | 93.66% |
| September 30, 2013 | 87.67% |
| June 30, 2013 | 87.79% |
| March 31, 2013 | 86.98% |
| December 31, 2012 | 73.74% |
| September 30, 2012 | 88.53% |
| June 30, 2012 | 72.65% |
| March 31, 2012 | 91.06% |
| December 31, 2011 | 94.65% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
85.38%
Minimum
Dec 2023
89.27%
Maximum
Mar 2020
87.57%
Average
87.66%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 57.03% |
| Eli Lilly and Co | 80.91% |
| Regeneron Pharmaceuticals Inc | 86.21% |
| Alpine Immune Sciences Inc | -- |
| Editas Medicine Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 24.35% |
| Return on Assets | 18.66% |
| Return on Invested Capital | 24.35% |
| Profit Margin (Quarterly) | 40.87% |
| Operating Margin (Quarterly) | 45.20% |
| Return on Net Operating Assets | 71.50% |